Libtayo 350 MG/7 ML vial 7ML
Ended Awarded
- Contract number
- SPE2DB25FKPBF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,553
Award facts
- Contract value 100% obligated
- $19,553.19 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $19,553.19 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of LIBTAYO 350 mg/7 mL vials. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by September 23, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. LIBTAYO (cemiplimab) is a monoclonal antibody immunotherapy used in cancer treatment, reflecting AmerisourceBergen's role as a critical supplier of specialty pharmaceutical products to federal healthcare systems.
This delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply brand-name and generic medications, specialty drugs, and medical supplies to military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's continued selection for pharmaceutical procurement demonstrates its competitive capability and established infrastructure for meeting federal medical supply requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FKPBF?
SPE2DB25FKPBF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 2, 2025.
How much is contract SPE2DB25FKPBF worth?
The government has obligated $19,553 on SPE2DB25FKPBF.
Is contract SPE2DB25FKPBF an order under another contract?
Yes. SPE2DB25FKPBF is a delivery order under SPE2DB24D2101, an indefinite delivery contract.
Was contract SPE2DB25FKPBF competed?
The extent of competition for SPE2DB25FKPBF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award